This enduring nature subsequently holds the potential to modulate TBX3’s control of cell cycle regulators such as p14/p19ARF, and subsequently, its engagement in pivotal biological processes associated with tumorigenesis, encompassing but not confined to cancer stem cell expansion, bypassing of cellular senescence, anti-apoptosis, and uncontrolled cell proliferation. Here, CDKN2A is linked to cancer.